ClinicalTrials.gg
Drug

Paliperidone clinical trials

Also written Invega, Invega Sustenna and JNS010.

studies test it
136
open now
6
in phase 3
51
first study started
2003

How each study uses paliperidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the paliperidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 2006 · INVEGA · NDA 021999 (FDA, Drugs@FDA)
European Union
24 Jun 2007 · Invega · EMEA/H/C/000746 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Paliperidone ER
41
Paliperidone
31
paliperidone palmitate
31
R076477
6
ER OROS paliperidone
6

Brand

Invega
18
Invega Sustenna
5
Xeplion
2
ERZOFRI
1

Development codes

JNS010
2
SYHF2036
1
SYHF2037
1

Other names

9-hydroxyrisperidone
1

Studies by the year they started

136 studies that test it; most in 2007 (18)

Studies that test paliperidone, by start year
YearStudies
20034
200412
20057
200611
200718
200814
200911
201013
20116
20126
20135
20142
20158
20162
20172
20182
20192
20201
20213
20221
20232
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
25
Phase 2
9
Phase 3
51
Phase 4
49
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 103 · Other 33

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (40) · Janssen Research & Development, LLC (14) · Janssen Pharmaceutical K.K. (7) · Janssen-Cilag International NV (6) · Janssen Korea, Ltd., Korea (5) · Xian-Janssen Pharmaceutical Ltd. (4) · Johnson & Johnson Taiwan Ltd (4) · Janssen Scientific Affairs, LLC (3)

Often tested with

Tested in the same studies.

Risperidone (14) · Aripiprazole (7) · Olanzapine (6) · Quetiapine (4) · Valproic Acid (3) · Amisulpride (2) · Haloperidol (2) · Perphenazine (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test paliperidone.

Studies

Open first, then newest update. How each study uses paliperidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 136

See all 136 studies that test paliperidone →

Given beside what is tested · 2 — paliperidone is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with paliperidone

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call paliperidone · ClinicalTrials.gg INT006556

  • MeSH (NLM) D000068882Paliperidone PalmitateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 838F01T721PALIPERIDONEConfirmed FDA, NLM, Wikidata
  • RxNorm 679314Confirmed FDA, Wikidata
  • Wikidata Q423292paliperidoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66293PaliperidoneOne source FDA
  • DrugBank DB01267One source Wikidata

Also registered as paliperidone palmitate (UNII R8P8USM8FR · RxNorm 858045).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.